Title
dfrA thyA double deletion in para-Aminosalicylic acid-resistant Mycobacterium tuberculosis Beijing strains
Date Issued
01 June 2016
Access level
open access
Resource Type
journal article
Author(s)
Moradigaravand D.
Grandjean L.
Martinez E.
Li H.
Zheng J.
Török M.E.
Sintchenko V.
Huang H.
Javid B.
Parkhill J.
Peacock S.J.
Köser C.U.
Publisher(s)
American Society for Microbiology
Start page
3864
End page
3867
Volume
60
Issue
6
Language
English
OCDE Knowledge area
Farmacología, Farmacia
Enfermedades infecciosas
Scopus EID
2-s2.0-84973596395
PubMed ID
Source
Antimicrobial Agents and Chemotherapy
ISSN of the container
00664804
Sponsor(s)
We thank L. Camacho for helpful comments regarding this topic. M. E. Török, J. Parkhill, S. J. Peacock, and C. U. Köser have collaborated with Illumina, Inc., on a number of scientific projects. M. E. Török and S. J. Peacock have received funding for travel and accommodation from Illumina, Inc. J. Parkhill has received funding for travel and accommodation from Pacific Biosciences, Inc., and Illumina, Inc. B. Javid is a Tsinghua-Janssen Scholar. C. U. Köser is a consultant for the Foundation for Innovative New Diagnostics and was a technical advisor for the Tuberculosis Guideline Development Group of the World Health Organization. The Bill and Melinda Gates Foundation and Janssen Pharmaceutica covered C. U. Köser's travel and accommodation to present at meetings. The European Society of Mycobacteriology awarded C. U. Köser the Gertrud Meissner Award, which is sponsored by Hain Lifescience. All other authors have no conflicts of interest to declare. This publication presents independent research supported by the Health Innovation Challenge Fund (HICF-T5-342 and WT098600), a parallel funding partnership between the United Kingdom Department of Health and the Wellcome Trust, and grant SRG2015-00006-FHS from the University of Macau. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health, Public Health England, or the Wellcome Trust. M. E. Török is a Clinician Scientist Fellow funded by the Academy of Medical Sciences, the Health Foundation, and the NIHR Cambridge Biomedical Research Centre. E. Martinez was supported by the Australian National Health and Medical Research Council's Centre for Research Excellence in Tuberculosis. C. U. Köser is a Junior Research Fellow at Wolfson College, Cambridge, United Kingdom.
Sources of information:
Directorio de Producción Científica
Scopus